Immunocore Earnings
NASDAQ: IMCRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.10
Immunocore earnings summary
Immunocore is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.10. In its most recent report on Aug 6, 2026 (Q2 2026), IMCR posted EPS of $-0.02. Revenue for the quarter was $115.9 million.
Across the last 11 reports, IMCR shares moved an average of 5.1% (in either direction) in the first trading session after results, rising 6 times and falling 5 times.
Summary generated from market data by MetaCap's automated system. Methodology
IMCR earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-0.02 | — | +0.6% |
| May 6, 2026 | — | $0.25 | — | -5.2% |
| Feb 25, 2026 | — | $-0.61 | — | +2.0% |
| Nov 6, 2025 | — | $0.00 | — | +7.3% |
| Aug 7, 2025 | — | $-0.20 | — | +2.8% |
| May 7, 2025 | — | $0.10 | — | +6.9% |
| Feb 26, 2025 | — | $-0.47 | — | +1.5% |
| Nov 6, 2024 | — | $0.17 | — | -8.9% |
| Aug 8, 2024 | — | $-0.23 | — | -2.2% |
| May 8, 2024 | — | $-0.49 | — | -9.6% |
| Feb 28, 2024 | — | $-0.40 | — | -8.6% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.